NCT01363700: Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis |
|
|
| Completed | 3 | 87 | Japan | DE-114 ophthalmic solution, Epinastine ophthalmic solution, Placebo ophthalmic solution, Olopatadine Hydrochloride 0.1% Ophthalmic Solution | Santen Pharmaceutical Co., Ltd. | Allergic Conjunctivitis | 06/12 | | | |
NCT01363713: A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis |
|
|
| Completed | 3 | 130 | Japan | DE-114 ophthalmic solution | Santen Pharmaceutical Co., Ltd. | Allergic Conjunctivitis | 09/12 | | | |
